8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms

Bioorganic & Medicinal Chemistry
Russell A GrubbsDavid E Nichols


The synthesis and preliminary pharmacological evaluation of 8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (5, now named dinoxyline) is described. This molecule was designed as a potential bioisostere that would conserve the essential elements of our beta-phenyldopamine D(1) pharmacophore (i.e., position and orientation of the nitrogen, hydroxyls, and phenyl rings). Previously, we have rigidified these elements using alkyl bridges, as exemplified in the dopamine D(1) full agonist molecules dihydrexidine (1) and dinapsoline (2). This approach has been modified and we now show that it is possible to tether these elements using an ether linkage. Preliminary pharmacology has revealed that 5 is a potent full D(1) agonist (K(0.5) <10 nM; EC(50)=30 nM), but also has high affinity for brain D(2)-like and cloned D(2) and D(3) receptors. Interestingly, whereas 1 and 2 and their analogues have only moderate affinity for the human D(4) receptor, 5 also has high affinity for this isoform. Moreover, although N-alkylation of 1 and 2 increases D(2) affinity, the N-allyl (15) and N-n-propyl (17) derivatives of 5 had decreased D(2) affinity. Therefore, 5 may be engaging different amino acid residues than do 1 and 2 when they b...Continue Reading


Oct 1, 1992·Brain Research. Molecular Brain Research·G W HuntleyS C Sealfon
Jul 1, 1995·Brain Research. Molecular Brain Research·W S ChoiO K Ronnekleiv
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·Y Y Huang, E R Kandel
Mar 1, 1995·Neurology·E C WoltersM A Kuiper
Sep 1, 1994·Brain Research. Molecular Brain Research·L G LaurierS R George
Jul 9, 1993·Brain Research·M S RappaportJ H Morrison
Dec 1, 1995·Neurology·W KantakamalakulJ Hay
Jun 24, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A D PatersonJ L Kennedy
May 23, 2002·The Journal of Pharmacology and Experimental Therapeutics·David M MottolaRichard B Mailman

❮ Previous
Next ❯


Aug 3, 2005·Psychopharmacology·Mark R Wade, George G Nomikos
Jul 22, 2008·Medicinal Research Reviews·Jing ZhangAo Zhang
Jun 14, 2012·Chemistry : a European Journal·Nelson R VinuezaHilkka I Kenttämaa
Jun 30, 2005·Molecular Pharmacology·Jessica P Ryman-RasmussenRichard B Mailman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.